Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review

Paschalis Karakasis1, Athina Nasoufidou1, Marios Sagris2

  • 1Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece.

PubMed

Insights

COVID-19 infection significantly impacts the vascular system, causing short and long-term issues like inflammation and clotting. This review explores these vascular effects and prevention strategies for better patient outcomes.

Area of Science:

  • Cardiovascular Science
  • Infectious Diseases
  • Pathology

Background:

  • SARS-CoV-2 (COVID-19) extends beyond respiratory effects, primarily targeting the vascular system.
  • The infection triggers endothelial dysfunction, inflammation, and a hypercoagulable state, impacting both micro and macrovasculature.

Purpose of the Study:

  • To comprehensively review short and long-term vascular alterations post-COVID-19.
  • To investigate the impact of these vascular changes on patient prognosis.
  • To outline preventive strategies for managing COVID-19-associated vascular complications.

Main Methods:

  • Review of existing literature on vascular manifestations of COVID-19.
  • Analysis of data from imaging modalities (e.g., MRI) and histopathological studies.
  • Inclusion of diagnostic tools like video capillaroscopy.

Main Results:

  • COVID-19 causes diverse vascular issues including thromboembolism, cardiovascular events, cerebrovascular complications, nephropathy, and retinopathy.
  • Persistent vascular effects, termed long-term COVID-19, involve prolonged inflammation and endotheliopathy.
  • Vascular alterations are frequently observed in severe illness and may persist long-term.

Conclusions:

  • SARS-CoV-2 infection poses significant risks to the vascular system, both acutely and chronically.
  • Understanding these vascular complications is crucial for improving patient prognosis.
  • Preventive measures are essential to mitigate long-term vascular sequelae of COVID-19.